Novaccess Global Stock Performance
| XSNX Stock | USD 0.0001 0.00 0.00% |
The company secures a Beta (Market Risk) of -3.21, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NovAccess Global are expected to decrease by larger amounts. On the other hand, during market turmoil, NovAccess Global is expected to outperform it. At this point, NovAccess Global has a negative expected return of -0.27%. Please make sure to verify NovAccess Global's risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and day median price , to decide if NovAccess Global performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days NovAccess Global has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
NovAccess |
NovAccess Global Relative Risk vs. Return Landscape
If you would invest 0.03 in NovAccess Global on October 12, 2025 and sell it today you would lose (0.02) from holding NovAccess Global or give up 66.67% of portfolio value over 90 days. NovAccess Global is currently does not generate positive expected returns and assumes 16.6645% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than NovAccess, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NovAccess Global Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NovAccess Global's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as NovAccess Global, and traders can use it to determine the average amount a NovAccess Global's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0161
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | XSNX |
Based on monthly moving average NovAccess Global is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovAccess Global by adding NovAccess Global to a well-diversified portfolio.
NovAccess Global Fundamentals Growth
NovAccess Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of NovAccess Global, and NovAccess Global fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NovAccess Pink Sheet performance.
| Return On Asset | -5.13 | |||
| Current Valuation | 5.75 M | |||
| Shares Outstanding | 19.57 M | |||
| Price To Earning | 2.69 X | |||
| Price To Sales | 2.87 X | |||
| EBITDA | (21.5 K) | |||
| Cash And Equivalents | 89.94 K | |||
| Total Debt | 165.88 K | |||
| Book Value Per Share | (0.50) X | |||
| Cash Flow From Operations | (903.49 K) | |||
| Earnings Per Share | (0.24) X | |||
| Total Asset | 124.9 K | |||
| Retained Earnings | (42.63 M) | |||
| Current Asset | 65 K | |||
| Current Liabilities | 791 K | |||
About NovAccess Global Performance
Evaluating NovAccess Global's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if NovAccess Global has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NovAccess Global has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.Things to note about NovAccess Global performance evaluation
Checking the ongoing alerts about NovAccess Global for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for NovAccess Global help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NovAccess Global generated a negative expected return over the last 90 days | |
| NovAccess Global has high historical volatility and very poor performance | |
| NovAccess Global has some characteristics of a very speculative penny stock | |
| NovAccess Global currently holds 165.88 K in liabilities. NovAccess Global has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NovAccess Global until it has trouble settling it off, either with new capital or with free cash flow. So, NovAccess Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NovAccess Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NovAccess to invest in growth at high rates of return. When we think about NovAccess Global's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.72 M) with profit before overhead, payroll, taxes, and interest of 752.56 K. | |
| NovAccess Global currently holds about 89.94 K in cash with (903.49 K) of positive cash flow from operations. | |
| Roughly 53.0% of the company outstanding shares are owned by insiders |
- Analyzing NovAccess Global's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NovAccess Global's stock is overvalued or undervalued compared to its peers.
- Examining NovAccess Global's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NovAccess Global's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NovAccess Global's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NovAccess Global's pink sheet. These opinions can provide insight into NovAccess Global's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.